00000nam 22000008a 4500 9.844013 CaOODSP 20221107152642 cr ||||||||||| 170919s2017 onca o f000 0 eng d 978-0-660-09799-2 CaOODSP eng n-cn--- H82-29/1-2017E-PDF Alignment among public formularies in Canada, part 1. [electronic resource] General overview. Ottawa : Patented Medicine Prices Review Board, 2017. iii, 31 p. : figs. Issued also in French under title: Concordance des listes de médicaments des régimes publics au Canada, partie 1 : Aperçu général. Cover title. Includes bibliographical references. "This first report in the series provides insight into the degree of alignment among the formularies. Based on 2015 data, this analysis compares the overall drug listings and unpacks specific market segments including single- and multi-source drugs, high-cost drugs, and a specified list of essential medicines."--Executive summary, p. ii. gccst Drugs gccst Drug insurance Canada. Patented Medicine Prices Review Board. Concordance des listes de médicaments des régimes publics au Canada, partie 1. (CaOODSP)9.844019 PDF 1.83 MB https://publications.gc.ca/collections/collection_2017/cepmb-pmprb/H82-29-1-2017-eng.pdf